Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
This study has been completed.
Study NCT00044395   Information provided by Eli Lilly and Company
First Received: August 28, 2002   Last Updated: November 5, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Neuropathies
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Peripheral Nervous System Diseases
More general conditions related to this trial
Autoimmune Diseases
Diabetes Complications
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Nervous System Diseases
Neuromuscular Diseases
Interventions listed in this trial
Ruboxistaurin mesylate
Additional drug interventions recognized in this trial
Ruboxistaurin
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services